[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Radioactive Monoclonal Antibody Market Research Report Forecast 2017-2021

March 2017 | 125 pages | ID: C451E1BCBD6EN
S&P Consulting

US$ 2,480.00 US$ 3,100.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The China Radioactive Monoclonal Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Radioactive Monoclonal Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Radioactive Monoclonal Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

China Radioactive Monoclonal Antibody Market: Product Segment Analysis

Type 1
Type 2
Type 3

China Radioactive Monoclonal Antibody Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 RADIOACTIVE MONOCLONAL ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Radioactive Monoclonal Antibody
1.2 Radioactive Monoclonal Antibody Market Segmentation by Type
  1.2.1 China Production Market Share of Radioactive Monoclonal Antibody by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Radioactive Monoclonal Antibody Market Segmentation by Application
  1.3.1 Radioactive Monoclonal Antibody Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Radioactive Monoclonal Antibody (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON RADIOACTIVE MONOCLONAL ANTIBODY INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Radioactive Monoclonal Antibody Industry

CHAPTER 3 CHINA RADIOACTIVE MONOCLONAL ANTIBODY MARKET COMPETITION BY MANUFACTURERS

3.1 China Radioactive Monoclonal Antibody Production and Share by Manufacturers (2015 and 2016)
3.2 China Radioactive Monoclonal Antibody Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Radioactive Monoclonal Antibody Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Radioactive Monoclonal Antibody Manufacturing Base Distribution, Production Area and Product Type
3.5 Radioactive Monoclonal Antibody Market Competitive Situation and Trends
  3.5.1 Radioactive Monoclonal Antibody Market Concentration Rate
  3.5.2 Radioactive Monoclonal Antibody Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA RADIOACTIVE MONOCLONAL ANTIBODY CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Radioactive Monoclonal Antibody Capacity, Production and Growth (2012-2017)
4.2 China Radioactive Monoclonal Antibody Revenue and Growth (2012-2017)
4.3 China Radioactive Monoclonal Antibody Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA RADIOACTIVE MONOCLONAL ANTIBODY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Radioactive Monoclonal Antibody Production and Market Share by Type (2012-2017)
5.2 China Radioactive Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
5.3 China Radioactive Monoclonal Antibody Price by Type (2012-2017)
5.4 China Radioactive Monoclonal Antibody Production Growth by Type (2012-2017)

CHAPTER 6 CHINA RADIOACTIVE MONOCLONAL ANTIBODY MARKET ANALYSIS BY APPLICATION

6.1 China Radioactive Monoclonal Antibody Consumption and Market Share by Application (2012-2017)
6.2 China Radioactive Monoclonal Antibody Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURERS ANALYSIS

7.1 Pfizer Inc. (USA)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Abbott Laboratories (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Genentech Inc. (USA)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 GlaxoSmithKline Plc (UK)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Immunomedics, Inc. (USA)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Indevus Pharmaceuticals Inc. (USA)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Novartis AG (Switzerland)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 OSI Pharmaceuticals, Inc. (USA)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Paladin Labs Inc. (Canada)
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURING COST ANALYSIS

8.1 Radioactive Monoclonal Antibody Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Radioactive Monoclonal Antibody

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Radioactive Monoclonal Antibody Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA RADIOACTIVE MONOCLONAL ANTIBODY MARKET FORECAST (2017-2021)

12.1 China Radioactive Monoclonal Antibody Production, Revenue Forecast (2017-2021)
12.2 China Radioactive Monoclonal Antibody Production, Consumption Forecast by Regions (2017-2021)
12.3 China Radioactive Monoclonal Antibody Production Forecast by Type (2017-2021)
12.4 China Radioactive Monoclonal Antibody Consumption Forecast by Application (2017-2021)
12.5 Radioactive Monoclonal Antibody Price Forecast (2017-2021)

CHAPTER 13 APPENDIX
LIST OF TABLES AND FIGURES

Figure Picture of Radioactive Monoclonal Antibody
Figure China Production Market Share of Radioactive Monoclonal Antibody by Type 1n 2016
Table Radioactive Monoclonal Antibody Consumption Market Share by Application in 2016
Figure China Radioactive Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2021)
Table China Radioactive Monoclonal Antibody Capacity of Key Manufacturers (2015 and 2016)
Table China Radioactive Monoclonal Antibody Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Radioactive Monoclonal Antibody Capacity of Key Manufacturers in 2015
Figure China Radioactive Monoclonal Antibody Capacity of Key Manufacturers in 2016
Table China Radioactive Monoclonal Antibody Production of Key Manufacturers (2015 and 2016)
Table China Radioactive Monoclonal Antibody Production Share by Manufacturers (2015 and 2016)
Figure 2015 Radioactive Monoclonal Antibody Production Share by Manufacturers
Figure 2016 Radioactive Monoclonal Antibody Production Share by Manufacturers
Table China Radioactive Monoclonal Antibody Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Radioactive Monoclonal Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table 2016 China Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table China Market Radioactive Monoclonal Antibody Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Radioactive Monoclonal Antibody Average Price of Key Manufacturers in 2015
Table Manufacturers Radioactive Monoclonal Antibody Manufacturing Base Distribution and Sales Area
Table Manufacturers Radioactive Monoclonal Antibody Product Type
Figure Radioactive Monoclonal Antibody Market Share of Top 3 Manufacturers
Figure Radioactive Monoclonal Antibody Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Radioactive Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Market Share (2012-2017)
Figure Production Revenue Share of Radioactive Monoclonal Antibody by Type (2012-2017)
Figure 2015 Revenue Market Share of Radioactive Monoclonal Antibody by Type
Table China Radioactive Monoclonal Antibody Price by Type (2012-2017)
Figure China Radioactive Monoclonal Antibody Production Growth by Type (2012-2017)
Table China Radioactive Monoclonal Antibody Consumption by Application (2012-2017)
Table China Radioactive Monoclonal Antibody Consumption Market Share by Application (2012-2017)
Figure China Radioactive Monoclonal Antibody Consumption Market Share by Application in 2015
Table China Radioactive Monoclonal Antibody Consumption Growth Rate by Application (2012-2017)
Figure China Radioactive Monoclonal Antibody Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radioactive Monoclonal Antibody
Figure Manufacturing Process Analysis of Radioactive Monoclonal Antibody
Figure Radioactive Monoclonal Antibody Industrial Chain Analysis
Table Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
Table Major Buyers of Radioactive Monoclonal Antibody
Table Distributors/Traders List
Figure China Radioactive Monoclonal Antibody Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Table China Radioactive Monoclonal Antibody Production, Import, Export and Consumption Forecast (2017-2021)
Table China Radioactive Monoclonal Antibody Production Forecast by Type (2017-2021)
Table China Radioactive Monoclonal Antibody Consumption Forecast by Application (2017-2021)


More Publications